Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01713816 · ClinicalTrials.gov registry record

Human Brain Antioxidants During Oxidative Stress

A clinical trial, sponsored by University of Minnesota.

Completed
Registry status
52
Enrollment target

NCT01713816 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 52 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01713816 has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
52 participants
Enrollment target

Study Summary

Antioxidants are important for having a good memory and for smart thinking when people get old, and that is important for everyone's quality of life. This research will find out if normal aging and Alzheimer's disease use up brain antioxidants. It will develop a new imaging tool that can help doctors to stop cognitive decline.

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2013-06
Est. Completion 2018-07-24

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT01713816

The ClinicalTrials.gov registry entry for NCT01713816 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01713816 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01713816 about?

NCT01713816 is a clinical study titled "Human Brain Antioxidants During Oxidative Stress". Antioxidants are important for having a good memory and for smart thinking when people get old, and that is important for everyone's quality of life. This research will find out if normal aging and Alzheimer's disease use up brain antioxidants. It will develop a new imaging tool that can help doctor...

What is the current status of trial NCT01713816?

This trial is currently completed. The enrollment target is 52 participants. The study started on 2013-06. Estimated completion is 2018-07-24.

Who is sponsoring clinical trial NCT01713816?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.